about
sameAs
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingMajor reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trialPersonal protection of long lasting insecticide-treated nets in areas of Anopheles gambiae s.s. resistance to pyrethroidsDifferential Effects of Azithromycin, Doxycycline, and Cotrimoxazole in Ingested Blood on the Vectorial Capacity of Malaria MosquitoesNeemazal ® as a possible alternative control tool for malaria and African trypanosomiasis?Lessons learnt from 20 years surveillance of malaria drug resistance prior to the policy change in Burkina FasoVarB: a variation browsing and analysis tool for variants derived from next-generation sequencing dataSelection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina FasoPrevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-PyrimethamineA phase 3 trial of RTS,S/AS01 malaria vaccine in African infantsPopulation genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assayEfficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquineHRP2 and pLDH-Based Rapid Diagnostic Tests, Expert Microscopy, and PCR for Detection of Malaria Infection during Pregnancy and at Delivery in Areas of Varied Transmission: A Prospective Cohort Study in Burkina Faso and UgandaSeasonal vaccination against malaria: a potential use for an imperfect malaria vaccine.Characterization of Within-Host Plasmodium falciparum Diversity Using Next-Generation Sequence DataA Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataAn effective method to purify Plasmodium falciparum DNA directly from clinical blood samples for whole genome high-throughput sequencing.Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation.Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy changeSelection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina FasoA barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains.Caregiver recognition of childhood diarrhea, care seeking behaviors and home treatment practices in rural Burkina Faso: a cross-sectional survey.Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Multiple insecticide resistance in Anopheles gambiae s.l. populations from Burkina Faso, West AfricaRubella seroprevalence among pregnant women in Burkina Faso.Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria.Small-quantity lipid-based nutrient supplements, regardless of their zinc content, increase growth and reduce the prevalence of stunting and wasting in young burkinabe children: a cluster-randomized trial.Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites.Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds.Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina FasoRandomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina FasoAn analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina FasoArtesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.Effect of zinc added to a daily small-quantity lipid-based nutrient supplement on diarrhoea, malaria, fever and respiratory infections in young children in rural Burkina Faso: a cluster-randomised trial.Plant-Mediated Effects on Mosquito Capacity to Transmit Human Malaria.Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso.
P50
Q20901697-8DF8D17D-E2CA-4BA8-86A7-0BE53DD21258Q21245897-4FC06B93-E360-4809-A3F9-8CC04BA6B3CDQ25256590-B9C18FAD-1199-4A27-8339-BF47D634B3C7Q26315272-6DE3010F-6DD0-4F9B-AD58-CCEAF27890BAQ26315488-B2F096BC-6F6A-419F-818D-17224CD97DFAQ26748690-052031A8-0923-4D1F-B037-4136FBC50CECQ28030976-D44508C3-62F7-4E3B-B452-09C2D1EFBCC0Q28125901-142A4D0B-AC9F-4957-BE37-68DA6305F661Q28125923-98A8944D-5DE6-4536-AC05-4A7CF82C189DQ28278852-711C4E06-C73B-4418-9411-6CC5A29C62BAQ28478444-4323FF16-0E37-414D-AF47-2E8D3E583A68Q28542034-7CB7BC18-CBF6-402E-8396-49D8F4CA45A8Q28552340-D2DEFCC8-3C08-420B-9FEC-586A4FC12629Q30234589-B0A70798-B82B-4667-AF92-ADFAE02EA18EQ30303389-6F935067-8BF4-46D4-92DF-25A74A202717Q30379780-A5B8E6B0-810D-4A3A-AFA9-DDEF327BF439Q30391827-CE0E740D-F02C-4725-A5F8-34F1267D92B3Q30936416-F0455D84-86DC-4E8A-829D-CBB719E85B39Q31077064-1C3BC6D1-6959-45CA-BEBB-26CF55D4B4F5Q31153944-9899BB6B-3D26-4E22-9CA5-28045A1A6703Q33596068-0E3BD028-910F-4F10-AE90-2B5BE6D7C8BDQ33726272-CDC9523C-8B72-459A-B038-6FDE14FB4403Q33826359-970BF4F1-F2A6-4F14-A9D5-0FACF89F8552Q33848880-9E2CA0E5-DD69-4D66-9821-9CFFE5C23408Q34200682-886CCBB8-B71A-4E48-ADF5-ECB341FED4BCQ34281680-40DE1988-9186-4DC5-9FD1-446BFBCA8214Q34493681-823F19B9-6FF2-4439-8BCB-78414ECF42DEQ34654518-81002C9F-3F40-4A57-B05E-40D07F091B10Q35114250-C7EBF04D-03B9-4A83-B188-2B6E10949F94Q35224656-6CA2547C-174C-46FE-AC7B-5962918E640BQ35225690-6269A338-59A0-4BDD-9C2E-6C83CFCF17DBQ35712615-B9F2405F-9895-4E18-B95D-FBE78AF37CE7Q35760573-A7B43793-B565-41C5-A347-91729CFA0B8CQ35859844-E52A10CB-217E-4469-A614-E49CAF87D5A2Q35917820-B0E00299-3B4E-4BC0-B898-61EF514F2728Q35975011-AE2116F6-BC4B-406A-8523-938E21A8435DQ35986306-F5E2D4BF-6F74-446C-A458-B09C2ED7279CQ36053711-D9397EE1-A6E6-43E1-991D-17A57F5FED42Q36094882-08AD0DC7-471C-48AA-A492-54B898376607Q36162404-FD1C0F39-578B-4CC5-92D8-B092DE0F61A0
P50
description
hulumtues
@sq
parasitoloog uit Burkina Faso
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jean-Bosco Ouedraogo
@ast
Jean-Bosco Ouedraogo
@en
Jean-Bosco Ouedraogo
@es
Jean-Bosco Ouedraogo
@nl
Jean-Bosco Ouedraogo
@sl
type
label
Jean-Bosco Ouedraogo
@ast
Jean-Bosco Ouedraogo
@en
Jean-Bosco Ouedraogo
@es
Jean-Bosco Ouedraogo
@nl
Jean-Bosco Ouedraogo
@sl
altLabel
Jean Bosco Ouedraogo
@ast
Jean Bosco Ouedraogo
@en
Jean Bosco Ouedraogo
@es
Jean Bosco Ouedraogo
@nl
Jean-Bosco Ouédraogo
@en
prefLabel
Jean-Bosco Ouedraogo
@ast
Jean-Bosco Ouedraogo
@en
Jean-Bosco Ouedraogo
@es
Jean-Bosco Ouedraogo
@nl
Jean-Bosco Ouedraogo
@sl
P106
P1960
J36LQBgAAAAJ
P21
P214
2333147665812160670008
P27
P31
P496
0000-0003-0412-8733
P7859
viaf-2333147665812160670008